missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human Laminin beta-3 (aa 1027-1156) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (75%), Rat (75%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The product encoded by this gene is a laminin that belongs to a family of basement membrane proteins. This protein is a beta subunit laminin, which together with an alpha and a gamma subunit, forms laminin-5. Mutations in this gene cause epidermolysis bullosa junctional Herlitz type, and generalized atrophic benign epidermolysis bullosa, diseases that are characterized by blistering of the skin. Multiple alternatively spliced transcript variants that encode the same protein have been found for this gene.
Specifications
Specifications
| Accession Number | Q13751 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 3914 |
| Name | Human Laminin beta-3 (aa 1027-1156) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | AI1A; BM600-125 KDA; Epiligrin subunit bata; kalinin B1 chain; Kalinin subunit beta; kalinin-140 kDa; LAM5; Lamb3; Laminin B1k chain; laminin beta 3; laminin chain; laminin S B3 chain; laminin subunit beta 3; laminin subunit beta-3; laminin, beta 3; laminin, beta 3 (nicein (125 kD), kalinin (140 kD), BM600 (125 kD)); laminin-5 subunit beta; LAMNB1; Nicein subunit beta; nicein, 125 kD; nicein, 125 kDa; nicein-125 k; nicein-125 kDa; RP1-272L16.3 |
| Common Name | Laminin beta-3 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction